FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

741611000001106: Cogentin 2mg tablets (Organon Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1737041000001110 Cogentin 2mg tablets (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1737051000001113 Cogentin 2mg tablets (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Is a Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Has active ingredient Benzatropine mesilate false Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Is a Cogentin true Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Has specific active ingredient Benzatropine mesilate true Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) 60 tablet Is pack of False Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Cogentin 2mg tablets (Organon Pharma (UK) Ltd) 60 tablet Has AMP True Cogentin 2mg tablets (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start